Further Refining Which Subgroups of Patients With Ovarian Cancer Benefit Most From Addition of Olaparib to Maintenance Therapy With Bevacizumab

Gynecologic Oncology News Updates

Stay up to date on the latest news from SGO and news from the industry. If you’re a member, make sure your account is signed up for these updates. If you’re not a member, contact us and we’ll add you to our list.